Diversity among multidrug-resistant enterococci.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
Clear All

Diversity among multidrug-resistant enterococci.

  • Published Date:

    1998 Jan-Mar

  • Source:
    Emerg Infect Dis. 4(1):37-47.
Filetype[PDF-66.33 KB]

  • Alternative Title:
    Emerg Infect Dis
  • Personal Author:
  • Description:
    Enterococci are associated with both community- and hospital-acquired infections. Even though they do not cause severe systemic inflammatory responses, such as septic shock, enterococci present a therapeutic challenge because of their resistance to a vast array of antimicrobial drugs, including cell-wall active agents, all commercially available aminoglycosides, penicillin and ampicillin, and vancomycin. The combination of the latter two occurs disproportionately in strains resistant to many other antimicrobial drugs. The propensity of enterococci to acquire resistance may relate to their ability to participate in various forms of conjugation, which can result in the spread of genes as part of conjugative transposons, pheromone-responsive plasmids, or broad host-range plasmids. Enterococcal hardiness likely adds to resistance by facilitating survival in the environment (and thus enhancing potential spread from person to person) of a multidrug-resistant clone. The combination of these attributes within the genus Enterococcus suggests that these bacteria and their resistance to antimicrobial drugs will continue to pose a challenge.
  • Document Type:
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like: